NCT04698811 is a NA clinical trial of VIRTUAL ENEAGRAM in Personality, sponsored by Universidade do Vale do Sapucai.

Who is sponsoring NCT04698811?

NCT04698811 is sponsored by Universidade do Vale do Sapucai.

What drugs are being tested in NCT04698811?

Interventions in NCT04698811: VIRTUAL ENEAGRAM.

What condition does NCT04698811 study?

NCT04698811 studies Personality.

Is NCT04698811 still recruiting?

NCT04698811 is currently completed. Last updated 14 October 2021.

Last reviewed 2021-10-14 · How we verify

NCT04698811

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Eneagram: Quality of Life, Stress and Anxiety.

Completed NA Last updated 14 October 2021

What this trial tests

NA trial testing VIRTUAL ENEAGRAM in Personality in 135 participants. Completed in 5 April 2021.

Timeline

18 November 2020

Primary endpoint
5 February 2021

5 April 2021

Quick facts

Lead sponsor	Universidade do Vale do Sapucai
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	135
Start date	18 November 2020
Primary completion	5 February 2021
Estimated completion	5 April 2021
Sites	1 location across Brazil

Drugs / interventions tested

VIRTUAL ENEAGRAM

Conditions studied

Personality — all drugs for Personality →

Sponsor

Universidade do Vale do Sapucai — full company profile →

Who can join

18 and older, any sex, with Personality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objetictive is to observe the influence of the enneagram typology on the perception of anxiety, stress and quality of life through self-knowledge directed in a virtual learning environment. The study is a clinical, primary, analytical, prospective and longitudinal study. It will be carried out in a virtual learning environment (VLE) with the collection of data obtained before and after the beginning of the training on the enneagram. The training will be divided into three online AVA modules. Casuistry: after orientations and signature of the term (Informed Consent Form), they will register on social networks where the initial information will be filled out. to outline the group. Inclusion criteria: participants of both sexes, Brazilians, over 18 years old; agree to sign the Informed Consent Form; with the desire to realize self-knowledge with the availability of time and access to the internet to hold meetings; Non-inclusion criteria: do not have previous information about the enneagram and speak the Portuguese language; Exclusion criteria: participation in work at any time; Individuals who have missed the modules and do not do the replacement later. Instruments: World Health Organization Quality of Life - (WHOQOL-BREF). Stress Perception Scale 10 (EPS-10) The Trait-State Anxiety Inventory: STAI E and T.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade do Vale do Sapucai trials

Trials by the same sponsor.

NCT06427733 — Green Banana Peel Extract for Stasis Dermatitis Treatment · Phase 1 · completed
NCT05031689 — Green Banana Peel Extract for Melasma Treatment · Phase 1 · completed
NCT05141864 — Acmella Oleracea in the Analgesia of the Digital Rectal Examination · Phase 1 · completed
NCT05252117 — Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Cop · Phase 4 · unknown
NCT04696224 — Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04698811 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade do Vale do Sapucai
Last refreshed: 14 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04698811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing